U.S. Court of Appeals for the Federal Circuit, 2022

Tris Pharma, Inc. v. Teva Pharmaceuticals USA, Inc.

Tris Pharma, Inc. v. Teva Pharmaceuticals USA, Inc.
U.S. Court of Appeals for the Federal Circuit · Decided December 14, 2022

Tris Pharma, Inc. v. Teva Pharmaceuticals USA, Inc.

Opinion

Case: 23-1158 Document: 5 Page: 1 Filed: 12/14/2022

NOTE: This order is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________ TRIS PHARMA, INC., Plaintiff-Appellee v. TEVA PHARMACEUTICALS USA, INC., Defendant-Appellant ______________________ 2023-1158 ______________________ Appeal from the United States District Court for the District of New Jersey in No. 2:20-cv-05212-KM-ESK, Judge Kevin McNulty. ______________________ ON MOTION ______________________ ORDER Teva Pharmaceuticals USA, Inc. moves to voluntarily dismiss this appeal pursuant to Rule 42 of the Federal Rules of Appellate Procedure, stating that “[n]o costs are due” and that Tris Pharma, Inc. does not oppose the mo- tion. Mot. at 1.

Upon consideration thereof, Case: 23-1158 Document: 5 Page: 2 Filed: 12/14/2022

2 TRIS PHARMA, INC. v. TEVA PHARMACEUTICALS USA, INC.

IT IS ORDERED THAT: (1) The motion is granted. The appeal is dismissed. (2) The parties shall bear their own costs.

FOR THE COURT December 14, 2022 /s/ Peter R. Marksteiner Date Peter R. Marksteiner Clerk of Court

ISSUED AS A MANDATE: December 14, 2022

Case-law data current through December 31, 2025. Source: CourtListener bulk data.